remain bullish follow mark solid core trend strong
script growth robust rais guidanc addit integr
synergies/cost save track consum centric effort continu
progress remain bullish build momentum/growth prospect
beyond continu view well posit given
uniqu collect asset integr offer clinic capabl view
valuat risk/reward attract reiter buy rate rais
price target ep
retail/ltc pharmaci put strong result claim growth yoy
adjust oper incom aid strong trend
mainten choic ingeniorx specialti growth improv purchas
econom encouragingli net new busi sell season
improv sequenti fep contract mail retail
extend earli feedback sell season
encourag think compani offering/uniqu collect asset
well posit specialti growth remain strong compani
also benefit time new gener given increas
custom focu expect specialti remain high growth area see
attract opportun unmanag specialti spend medic benefit
retail/ltc segment saw anoth strong script growth ss script
drive market share gain bp addit
front store ss sale increas bp health beauti compani
saw modest benefit gener adjust oi yoy
continu reimburs pressur howev head wind continu narrow
sequenti part on-going portfolio optim effort compani
expect close retail pharmaci locat
benefit segment continu perform well driven govern segment
compani look pois anoth strong year segment
enrol saw anoth sequenti improv ad live
continu post industri lead qualiti rate averag
star rate member enrol rate plan
total medicaid enrol also grew qoq addit member
notabl compani award four region texa
medicaid re-procur previou region winner
west virginia children youth program contract final
strong qualiti rate digit capabl high patient touch point
tr target
attract specialti offer continu see opportun leverag exist silverscript
platform drive cross-sel saw modest sequenti improv around cost pressur
portion lower-end middl market commerci book full year guidanc mbr /-
unchang
health innov seen encourag earli result pilot
healthhub houston tx compani plan roll addit locat three
metro area year end addit patient touch point conveni retail locat
compani expect expans drive earn contribut via greater use increment
products/servic higher medic cost save aet book next best outcom deeper medical/
pharmaci integr abil deliv enhanc offer health plan relationship
increas consum satisfact compani continu expect hub end
like neighborhood end also launch oncolog pilot select
market roll care transit program heal better incorpor
certain plan final first phase chronic kidney manag
program underway progress second phase program person counsel
modal home hemodialysi trial track in-lin expect remain bullish
chronic diseas offer given percentag total healthcar spend think kidney diseas focu
dovetail nice arch industri driver expect capabl aid enrol lower
cost improv outcom time
strong bump full year guidanc result came better across board
adjust ep ahead consensu estim net revenu
ahead think vs strhe larg driven perform pharmaci
vs strhe better claim volum net new busi win mainten choic
ingeniorx top line beat coupl oi margin roughli in-lin better
mbr vs strhe favor prior year develop net realiz capit gain
health benefit segment shift aet mail order specialti oper pharmaci
off-set declin retail/ltc reimburs pressur adjust oi coupl
better interest expense/oth aid adjust ep beat full-year adjust ep guidanc
rais narrow vs prior cffo guidanc
cap ex unchang
remain robust tweak estim flow trend remain strong cffo
come comfort ahead estim
manag reiter full year cffo guidanc addit dcp increas
day sequenti day compani paid dividend decreas net debt
compani also refinanc outstand senior debt extend matur
lower cost capit updat full year adjust ep estim
 bump trim reflect results/upd
guidanc remain bullish like strong cash gener uniqu collect asset
attract risk/reward reiter buy rate rais price target
page
product sold
product revenu
rev
rev
rev
rev
page
health corpor base woonsocket ri oper retail store
walk-in medic clinic provid health insur product across commerci
govern sector oper lead pbm serv member state district
columbia puerto rico brazil acquisit aetna carri number benefit combin
expect drive increas effici strong cost synergi attract underli growth
bullish tie uniqu set asset robust clinic capabl expand
presenc attract medicar busi addit given strength legaci
aet busi view integr pharmacy/med benefit well posit like
combin compani high patient touch model think grow import given
environ increasingli driven consum choic focus total patient care final think
signific scale across busi line strong balanc sheet robust cash flow gener
allow effect de-lev provid dri powder on-going capit deploy
activ time rate share buy
valuat risk
price target base stock trade adjust ep premium
current multipl manag care peer view warrant given sizabl retail
exposur risk rate pt includ deterior pbm retent rate increas
regulatori scrutini reimburs pressur inabl integr aetna effect loss retail
market share tie increas competit
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
